An Overview of Viruses and Anti-viral Immune Support

Fact Checked
Written by
Medically reviewed by
Dr. Alex Keller, ND
Blog Conditions
An Overview of Viruses and Anti-viral Immune Suppor...

What is a virus?

Viruses are particles that exploit the RNA and DNA of other cellular life forms in order to proliferate and survive. The introduction of viruses to a host promotes viral propagation by altering the host’s normal genomic and metabolic state. (67)(115)

Viral invasion can lead to a variety of outcomes, ranging in severity. An infection may be acute, mild, and quickly resolved by the host’s immune system (e.g., the common cold), or the infection may be severe, even fatal, and lead to chronic disease. Commonly recognized viruses may include, but are not limited to, the following:

  • Ebola virus
  • Enterovirus
  • Epstein-Barr virus
  • Hepatitis viruses
  • Human immunodeficiency virus
  • Human respiratory syncytial virus
  • Human rhinovirus
  • Humanpapillomaviruses
  • Influenza viruses
  • Measles virus
  • Mumps virus
  • Poliovirus
  • Rabies virus
  • Rotaviruses
  • Varicella zoster virus
  • West Nile virus
  • Zika virus (51)(94)

How are viruses different from other pathogens?

Unlike bacteria, fungi, and eukaryotic parasites, which are living cells that use their own cellular DNA for replication, viruses are not living cells and require the genetic information present in host cells in order to replicate. Viruses are characterized by an outer protein shell, known as a capsid, which houses limited amounts of genetic material (RNA or DNA). The entirety of the genetic information and the outer protein shell is referred to as a virion. In order to replicate, the genetic information contained within the virion must be transmitted into a host cell. (5)

The outer surface of the virus possesses proteins recognized by specific cellular receptors on host cells, which initiates virus transmission. The virus’ genetic material can then penetrate the cellular nucleus to interact with the host’s DNA to produce mRNA, which ultimately leads to viral proteins that may generally be classified by three functional characteristics:

  • Viral replication enzymes
  • Proteins used in the composition of newly synthesized virions
  • Inhibitory proteins that prevent the host’s synthesis of DNA, RNA, and proteins (77)

The accumulation of virions in the host cell may eventually lead to cellular death as the infected cell either ruptures or disintegrates. Transmission then occurs by diffusion within extracellular space, transfer through temporary cellular membranes from non-lysed cells or other migratory cells, or by the carriage of the virus to non-infected cells through surface-to-surface contact. (77)(107)

mother feeling daughters forehead for temperature while being on the phone

Viral invasion can lead to a variety of symptoms, ranging in severity.

How are viruses classified?

While viral infections are often characterized by their pathogenic actions (e.g., respiratory viruses, gastrointestinal viruses, neurological viruses, etc.), viruses are more accurately classified by their characteristic RNA or DNA, as well as the mode by which they approach replication and expression. The seven classes of viruses are labelled as:

  1. (+)strand RNA viruses
  2. (-)strand RNA viruses
  3. Single-strand DNA viruses
  4. Dual-strand RNA viruses
  5. Dual-strand DNA viruses
  6. (+)strand RNA retroviruses
  7. Dual-strand DNA retroviruses (67)

RNA viruses contain RNA as their genetic material, while DNA viruses have DNA. The mechanisms of infection of RNA and DNA viruses typically produce acute and chronic viral infections, respectively. (28) Single strand RNA viruses such as (+)strand RNA viruses can match host mRNA and can be immediately translated into viral proteins, while (-)strand RNA complement viral mRNA but require conversion to (+)strand RNA before translation into viral proteins. (28)(67)

How your body responds to viruses

After a viral invasion, your body’s innate and adaptive immune systems respond to the virus’ presence. A variety of cellular receptors are used to recognize when a pathogen has invaded or created byproducts that are potentially harmful to the body. This ultimately leads to the upregulation of immune, pro-inflammatory, and other products that attempt to remove or interfere with viral replication. (11)

Current prevention and treatment approaches

Prevention of viruses mainly focuses on providing the body with a means of recognizing the pathogenic virus so that the immune system can ultimately react in a manner to disrupt viral spread. Vaccines are introduced into the body as a ‘practice run’ so that cellular receptors can effectively recognize and react to the presence of the viruses by inducing the immune system. (11)

Unlike bacterial pathogens, viruses cannot be killed by anti-microbials, and anti-biotics are often incorrectly prescribed to address viral infection. (96) Most viral infections do not require specific anti-viral drugs and are resolved by the body’s immune system. However, some anti-viral treatments may provide supportive functions by reducing the severity of symptoms or by suppressing viral recurrence. (12)(103)

Reducing your exposure and transmission of viruses

Viral transmission may depend on the relationship between the characteristics of potential hosts, a host’s environment, and the pathogen itself. Pathogens may spread to new locations as a result of travel, migration, or trade, particularly with the global ability of rapid air travel and increasing population density.

Furthermore, approximately 80% of human viral infections proliferate in animals and arthropods, which increases the risk of transmission following contact with vulnerable human populations. (94)

Viral susceptibility also varies based on the pathogen itself, as well as the characteristics of the host. Differences in health, nutritional and immune statuses, genetics, physiology, and age, as well as the presence of previous or simultaneous viral infections are all contributing factors. (94)

Practicing good hygiene is an effective way to reduce viral transmission.

close up of person washing their hands

Practicing good hygiene is an effective way to reduce viral transmission.

What can we do to support immune function and prevent viral infections?

Foods for immune support

Maintaining a healthy and balanced diet is intricately connected to proper immune function. (21) There are several food sources that contain anti-oxidant and anti-viral properties that may assist in providing immune system support.

Anti-oxidants prevent or reduce oxidative stress that is associated with most chronic diseases. Anti-oxidants can contribute to cellular maintenance, DNA repair, and longevity. Foods with the highest anti-oxidant profiles include berries, fruits, nuts, chocolate, and vegetables. Plant-based foods including spices and herbs also contain high proportions of anti-oxidants. (14)

Incorporation of herbs and spices into the diet is another way to ingest foods that have demonstrated anti-viral properties. Namely, immune supportive herbs or their active components, which can be found in other natural products such as supplements, and may specifically target viruses of the Coronavideae family include:

  • Artemisia annua (sweet wormwood)
  • Houttuynia cordata (chameleon’s plant)
  • Isatis indigotica (dyer’s woad)
  • Lindera aggregata (evergreen, spice bush)
  • Lycoris radiata (red spider lily)
  • Pyrrosia lingua (felt fern)
  • Torreya nucifera (Japanese nutmeg-yew)
  • Myricetin, saikosaponins or scutellarein (75)

Top 12 supplements for immune support for viral infections

The following provides a list of supplements that have been used as immune system support for viral infections.

1. Astragalus

The roots of Astragalus membranaceus have been used therapeutically for thousands of years in Traditional Chinese Medicine for its bioactive polysaccharides. As demonstrated in various studies, these polysaccharides possess widespread immunomodulatory, anti-inflammatory, anti-viral, anti-oxidant, and cardioprotective activities. (133)

In humans, Astragalus membranaceus formulations as injection or granules have been used as supportive therapy for myocarditis induced by viral infections. (42)(76) Oral liquid administrations have been shown to enhance cellular immunity in viral myocarditis patients. Specifically, OKT3, OKT4 cells and the OKT4/OKT8 ratio increase. (54) The use of 7.5 ml twice per day (equivalent to 1.23g of dry herb) for one week has also been shown to stimulate CD69 expression on white blood CD4 and CD8 T cells within 24 hours, which is maintained during the week of ingestion. (13) In comparison, stimulation of CD25 expression was greatest in the first day but not maintained over the rest of the week. (134)

Astragalus treatment can boost ɑ-interferon (ɑ-IFN) and γ-interferon (γ-IFN), cytokines which play roles in viral replication. (124) Its anti-viral properties have also been demonstrated in patients with chronic viral hepatitis B by promoting recovery from viral infection and by preventing viral replication (81)(114). Astragalus extracts can also reduce the level of anti-inflammatory IL-4 and IL-10 cytokines, while increasing pro-inflammatory IL-2 and immune response-inducing γ-IFN in patients with viral herpes simplex keratitis. IL-4 and IL-10 may be typically reduced, while IL-2 and γ-IFN may be typically higher in these patients. (80)

Astragalus membranaceus has also been shown to possess anti-influenza virus properties by modulating the expression of toll-like receptors (TLR) TLR3, transforming growth factor-β (TGF-β)-activated kinase 1 (TAK1), TRAF-family member associated NF-κB-activator (TANK) binding kinase 1 (TBK1), interferon regulatory factor 3 (IRF3), and interferon-β (IFN-β) in the TLR3-mediated signaling pathway in vitro. (74) TLR-mediated pathways are involved in the activation of various inflammatory responses with exposure to pathogens. (93) Furthermore, it provided anti-oxidative effects by increasing superoxide dismutase and reducing MDA. (74)

2. Echinacea

Echinacea (Echinacea purpurea) is a medicinal herb widely used for its immune-boosting properties. For common cold prevention, the use of a liquid extract, 0.9 ml three times per day (equivalent to 2400 mg of extract) for a minimum of four months has been used, while in the acute phase of cold development, up to 4.5 ml (4000 mg) has been used. (56) Meta-analysis shows that echinacea use may reduce the risk of common cold development by 10-58%, and days with cold by approximately a day and a half. (59)(108) Echinacea may reduce the incidence of cumulative viral infections by 26% and recurring infections by 59%, including the influenza virus and parainfluenza virus. (56) Its immune-boosting effects may be related to associated increases in immune cell counts including white blood cells, monocytes, neutrophils, and natural killer cells, which fight infection. Furthermore it may increase the suppression free radical production production in the later-phase of the cold by neutrophils. (38) Free radicals such as superoxide may have a role in the pathogenesis of viral infections. (4)

3. Elderberry

Black elderberry (Sambucus nigra) contains various bioactive constituents such as anthocyanins, which have been shown to have anti-viral and immune-stimulating properties. A 2019 meta-analysis showed that elderberry supplementation substantially reduced the symptoms of viral URTIs, particularly for the influenza virus. (44)

elderberry plant and juice extract

Black elderberry has been shown to have anti-viral and immune-stimulating properties.

Dosing and administration protocols have varied between published trials, but consistently improve symptoms of cold and flu, and reduce duration of infection. Two trials have shown efficacy with the administration of 15 ml (1 tablespoon) of an elderberry standardized extract syrup, four times per day to adults during meals for three to five days while children use half doses. (126)(127) Another study used slow-dissolving lozenges containing 175 mg of a proprietary elderberry extract, four times per day with meals and before bed, over two days. (66) Finally, proprietary extract capsules containing 300 mg of elderberry extract has been provided as two capsules per day for ten days prior to air-travel, and three capsules for four to five days at the destination have been used. (117)

4. Goldenseal

Goldenseal (Hydrastis canadensis) has been traditionally used as an anti-infectious ingredient, and now used in supplements for colds and respiratory tract infections, however, there is a current lack of human clinical trials using the whole plant or an extract. (88)

Goldenseal has been shown to inhibit the growth of influenza A and inflammatory markers in vitro. (17) It has also demonstrated anti-microbial activity against methicillin-resistant Staphylococcus aureus and Helicobacter pylori in vitro, which are two pathogenic bacteria responsible for the development of a variety of health conditions. (16)(23) Goldenseal may also modulate the anti-inflammatory and pro-inflammatory response as it may reduce the production of inflammatory biomarkers such as TNF-ɑ, interleukin IL-6, IL-10, and IL-12 from macrophages. (20) In rats, goldenseal also increased immunoglobulin M (IgM) response within two weeks of use. (104) IgM is produced in response to antigens and may protect against viral infections including influenza. (9)

One of the constituents of goldenseal, berberine, has also demonstrated anti-viral properties. In the lung cells of mice, berberine inhibited influenza virus replication and reduced the virus-induced alteration of immune cell ratios and rises in inflammatory markers. (123) It has also shown anti-viral activity in vitro to many other viruses by preventing viral entry and replication. Examples include Coxsackievirus B, Cytomegalovirus, Enterovirus, respiratory syncytial virus Hepatitis C, Zika viruses, to name a few. (8)(24)(55)(110)(121)(132)

5. L-lysine

The essential amino acid L-lysine has been used in a wide variety of applications. In relation to anti-viral therapy, L-lysine has been most studied for its uses in herpes simplex virus infections. (113) Many trials have used doses ranging between 300-3000 mg per day for up to one year for herpes prophylaxis and symptom treatment. (41)(82)(85)(111)(116) However, systematic reviews indicate that treatment with more than 1 gram may be required for prophylaxis or treatment of the herpes viruses, while doses greater than 3 grams per day can improve patient’s self-assessed improvements. (78)

A trial supplying 1000 mg of lysine per day for 16 weeks to a population where bacterial and viral causes of diarrhea commonly occur also showed a reduction in diarrhea episodes and days of sickness in children, while reducing the number of days with sickness and number of episodes of coryza in men. In women, serum ferritin and CRP levels decreased with lysine supplementation. (36) These biomarkers may be increased in the presence of influenza infections. (33)

mushrooms in a bowl and on a table

Intake of shiitake mushrooms has been shown to stimulate the immune response.

6. Mushrooms

Similarly to astragalus, mushrooms and their active components have been extensively used in Traditional Chinese Medicine for their immune-stimulating, anti-microbial, anti-fungal, anti-tumor, and anti-viral properties. (131)

Several in vitro studies have shown broad anti-viral effects, including anti-viral effects against influenza, using a variety of mushroom extracts including Ganoderma lucidum, Lentinus edodes, Grifola frondosa, Agaricus brasiliensis, (6)(32) Phellinus igniarius, (69) and Rozites caperata. (97) The following provides evidence for the use of medicinal mushrooms and their bioactive ingredients in viral infections from human trials.

Bioactive ingredients

The ingestion of lentinan, a major active substance in Lentinus edodes mushrooms at doses of 2.5 mg per day for six weeks also increased the number of circulating B lymphocytes in healthy elderly adults. (34) As an adjunct anti-viral therapy in patients with HIV, 2 mg (i.v.) of lentinan increased the CD4 cells for up to 38 weeks compared with anti-retroviral therapy alone. (40)

Another extract from Basidiomycetes mushrooms called the ‘active hexose correlated compound’ has been used to improve immune status of healthy individuals after receiving the influenza B vaccination. Ingesting 3 grams per day for three weeks post-vaccination increased the number of natural killer cells and CD8 T cells, and improved antibody titers to influenza B compared with vaccine alone. (105)

Agaricus blazei Murill (Cogumelo do Sol or Himematsutake)

The daily use of 1.5 grams of Agaricus blazei Murill has been safely used over one year to reduce aspartate and alanine aminotransferases in patients with hepatitis B. This may provide indication that Agaricus blazei Murill may assist in the normalization of liver function following its infection by the hepatitis virus. (52)

Lentinula edodes (Shiitake)

In healthy adults, the use of 5 to 10 grams of Shiitake mushrooms over four weeks has been shown to stimulate γδ-T cells, natural killer T cells, and secretory IgA, involved in the immune response. Consumption may alter the inflammatory profile as shown by reduced C-reactive protein (CRP), and macrophage inflammatory protein-1α/chemokine C-C ligand 3 (MIP-1α/CCL3) levels, and increased IL-4, IL-10, TNF-α, and IL-1α levels. (25)

Multi-mushroom products

Another medicinal mushroom product called Immune Assist 25/7™ containing compounds Lentinus edodes, Trametes versicolor, Ganoderma lucidum, Agaricus brasiliensis, Cordyceps sinensis, and Grifola frondosa at a dose of 2.4 g for two months increased CD4+ T-lymphocyte numbers in HIV patients. (1) The combination of Trametes versicolor and Ganoderma lucidum has been shown to clear oral human papillomavirus 16 and 18 after two months of treatment. (29)

7. Oregano

The herb, oregano (Origanum vulgare) is commonly used in the food, cosmetics, and pharmaceutical industries. The essential oils are now also used for their anti-microbial, anti-viral, and anti-fungal properties. (73)

Oregano essential oil bottles next to Oregano plant

Oregano essential oils are used for their anti-microbial, anti-viral, and anti-fungal properties.

Studies have assessed the anti-viral activity against certain viruses, including the murine norovirus, respiratory syncytial virus (RSV), Coxsackie virus B3 (CVB3), and herpes simplex virus type 1 in vitro. (37)(129)

8. Probiotics

Though probiotics have been most widely used for their beneficial effects in the GI tract, research now shows that a healthy composition of bacteria in the GI tract can translate to improved immune function. This can also lead to improved regulation of anti-inflammatory and pro-inflammatory cytokines, and anti-oxidative biomarkers. (7)(83)(106)(128)

The benefits of probiotics can extend beyond their anti-microbial effects to also provide support against viral infections. For example, research is showing the potential benefit of probiotics as an adjunct therapy for in the regulation of white blood CD4 cell counts in patients with human immunodeficiency virus (HIV). (15)(22)(60)(84)(122)

Meta-analyses show that probiotics may reduce cold severity and have minor effects on cold prevention, as well as improve influenza vaccination efficacy for A/H1N1, A/H3N2, and B strains, but is dependent on strain and population. (58)(71)(125) Meta-analyses also show the efficacy of probiotics in reducing rates of respiratory tract infections in adults and children. (27)(43)(64)(92)(120)

In children, the use of 5 billion CFU of Lactobacillus acidophilus NCFM (ATCC 700396), twice per day, for a minimum of six months has been shown to reduce the incidence and severity of cold symptoms, while 10 billion CFU of Bifidobacterium animalis subs. lactis Bi-07 (ATCC PTA-4802) and Lactobacillus acidophilus NCFM (ATCC 700396), had similar effects for influenza. (72)

In adults, the use of 1 billion CFU of Lactobacillus paracasei 8700:2 (DSM 13434) and Lactobacillus plantarum HEAL 9 (DSM 15312), once per day for three months can reduce the incidence of colds and symptoms. (10) For influenza, 10 billion CFU of Lactobacillus fermentum CECT5716, once per day for two weeks before influenza vaccination and two weeks after, or Lactobacillus rhamnosus GG, twice per day for four weeks after influenza vaccination may reduce the future incidence of influenza compared with vaccination alone by increasing seroprotection (the extent of increased antibodies in response to infection), as well as natural killer cells, the T-helper response, and immunoglobulin A levels. (26)(91) The use of another probiotic, Saccharomyces cerevisiae (EpiCor®) at a dose of 500 mg per day for 12 weeks may reduce the incidence of cold/flu symptoms with or without prior vaccination and the duration of symptoms with prior vaccination. (86)(87)

9. Quercetin

Quercetin, a flavonoid found in many plant-based foods, has also shown efficacy in reducing the incidence and severity of upper respiratory tract infection (URTI) symptoms. A dose of 1000 mg per day has been shown to reduce the severity of URTI symptoms as well as the number of sick days, particularly for adults over the age of 40. (45) The same dose over two weeks also reduced the incidence of URTIs in trained athletes. (89)

A derivative molecule of quercetin, quercetin 3-β-O-d-glucoside has been shown to provide protection against ebolaviruses in mice and in vitro. (101) Several other studies in vitro studies have demonstrated anti-viral properties against Influenza, Mayaro, Chikungunya, Epstein-Barr, and Hepatitis C viruses. (30)(61)(63)(68)(70)

Several studies also suggest that the combination of vitamin C and quercetin can provide synergistic effects for immune-boosting activity by reducing oxidative stress, and DNA damage. (3)(90)(95)

10. Vitamin C

Vitamin C is one of the most popular immune support vitamins when it comes to the common cold and flu. Systematic reviews and meta-analyses indicate that supplementation with a minimum of 200 mg in children and 1 g of vitamin C per day in adults may be used as an ongoing maintenance dose to boost immunity. Increasing the dose to 1 to 2 g in children and 3 to 4 g in adults at the onset of common cold symptoms can reduce the duration of infection. This may be a result of increased anti-microbial, and immune cell activities, as well as improved antioxidant capacity. (48)(102)

11. Vitamin D

Vitamin D has been shown to be involved in modulation of the immune system due to its ability to bind to vitamin D receptors expressed throughout the body’s nucleated cells, including antigen-presenting cells within the innate and adaptive immune systems. (18) Vitamin D insufficiencies or deficiencies have been linked to a variety of viral infections, including chronic hepatitis B, (53) hepatitis C virus, (119) or other viral infections leading to upper respiratory tract infections or pneumonia. (2)(98)

Vitamin D may also be used in the prevention and/or treatment of URTI in adults and children. One meta-analysis showed that doses ranging from 400 to 2000 IU per day over three months to three years reduced the incidence and number of events of respiratory tract infections in children and adults. (19) A four-month protocol of 400 IU of daily vitamin D also reduced the duration and severity of URTIs in adults. (109) In children aged one to five, daily administration of 400 IU for four months was equally as effective as 2000 IU in reducing the risk for wintertime URTIs, (2) though doses of 1200 IU for approximately four months in the winter can reduce the incidence of Influenza A in children aged six to 15, (118) and in infants of less than one year of age. (130) In older Vietnamese children aged three to 17, weekly ingestion of 14000 IU over eight months reduced the incidence of non-influenza respiratory virus infections, but not influenza infections. (78)

Vitamin D administration as an adjunct to other anti-viral therapies may have synergistic benefits in infections such as chronic hepatitis C (62) and HIV, (31) and may reduce inflammatory markers, such as TNF-α and IL-6, after influenza vaccination, while promoting transforming growth factor beta (TGF-β), a multifunctional cytokine involved in cell growth, proliferation, and programmed cellular death. (39)

12. Zinc

Zinc is also often recommended for its protective effect against the common cold. Zinc improves the anti-inflammatory and anti-oxidant profile by reducing in plasma interleukin-1 receptor antagonist, intercellular adhesion molecule-1, TNF-ɑ, malondialdehyde (MDA), 4-hydroxyalkenals (HAE), and 8-hydroxydeoxyguanine (8-oHdG), and increases in IL-2 mRNA in mononuclear cells. (99)(100) The symptoms of viral infections, including those of the common cold, are considered to be consequences of the increased presence of pro-inflammatory cytokines such as TNF-ɑ and many interleukins in response to viral invasion. (65) MDA, HAE, and 8-oHdG are examples of biomarkers that lead to the production of free radicals, (35) which, as previously described, may have roles in the pathogenesis of viral infections. (4)

Several systematic reviews and meta-analyses show that 75 to 100 mg of elemental zinc as zinc acetate or zinc gluconate lozenges, once per day, within 24 hours of the onset of common cold symptoms, minimum 1 to 2 weeks to reduce the duration and symptoms of colds, in adults and children. (46)(47)(49)(50)(57)(112)

The bottom line

Viruses are particles that require a host in order to proliferate and survive. Viral infections may be asymptomatic but can lead to mild symptoms and conditions, or more severe and chronic conditions, including death.

Practicing good hygiene can effectively reduce the risk of viral spread and infection, but maintaining a strong immune system to ensure appropriate immune responses to viral infections occur is critical. There are several best practices that can be used to support immune function, including several immune-boosting foods and supplements that may be used for their anti-viral properties.

Fullscript simplifies supplement dispensing

Create your dispensary today I'm a patient
Shareable protocols 2.0
Support group visits, attract new patients,
and collaborate more easily with colleagues!
Try now!

Don’t have a free Fullscript account? Sign up.

  1. Adotey, G., Quarcoo, A., Holliday, J., Fofie, S., & Saaka, B. (2011). Effect of immunomodulating and antiviral agent of medicinal mushrooms (immune assist 24/7 TM) on CD4+ T-lymphocyte counts of HIV-infected patients. International Journal of Medicinal Mushrooms, 13(2), 109-113.
  2. Aglipay, M., Birken, C. S., Parkin, P. C., Loeb, M. B., Thorpe, K., Chen, Y., … & Mazzulli, T. (2017). Effect of high-dose vs standard-dose wintertime vitamin D supplementation on viral upper respiratory tract infections in young healthy children. JAMA, 318(3), 245-254.
  3. Ajibade, T. O., Oyagbemi, A. A., Omobowale, T. O., Asenuga, E. R., & Adigun, K. O. (2017). Quercetin and vitamin C mitigate cobalt chloride-induced hypertension through reduction in oxidative stress and nuclear factor kappa beta (NF-Kb) expression in experimental rat model. Biological Trace Element Research, 175(2), 347-359.
  4. Akaike, T. (2001). Role of free radicals in viral pathogenesis and mutation. Reviews in Medical Virology, 11(2), 87-101.
  5. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., & Walter, P. (2002). Introduction to pathogens. In Molecular Biology of the Cell. 4th edition. Garland Science.
  6. Avtonomova, A. V., & Krasnopolskaya, L. M. (2014). Antiviral properties of basidiomycetes metabolites. Antibiotics and Chemotherapy, 59(7-8), 41-48.
  7. Azad, M., Kalam, A., Sarker, M., & Wan, D. (2018). Immunomodulatory effects of probiotics on cytokine profiles. BioMed Research International, 2018, 8063647.
  8. Batista, M. N., Braga, A. C. S., Campos, G. R. F., Souza, M. M., Matos, R. P. A. D., Lopes, T. Z., … & Bittar, C. (2019). Natural products isolated from oriental medicinal herbs inactivate zika virus. Viruses, 11(1), 49.
  9. Baumgarth, N., Herman, O. C., Jager, G. C., Brown, L. E., Herzenberg, L. A., & Chen, J. (2000). B-1 and B-2 cell–derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. The Journal of Experimental Medicine, 192(2), 271-280.
  10. Berggren, A., Ahrén, I. L., Larsson, N., & Önning, G. (2011). Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition, 50(3), 203-210.
  11. Braciale, T. J., & Hahn, Y. S. (2013). Immunity to viruses. Immunological Reviews, 255(1).
  12. Brendish, N. J., & Clark, T. W. (2017). Antiviral treatment of severe non-influenza respiratory virus infection. Current Opinion in Infectious Diseases, 30(6), 573-578.
  13. Brush, J., Mendenhall, E., Guggenheim, A., Chan, T., Connelly, E., Soumyanath, A., … & Zwickey, H. (2006). The effect of Echinacea purpurea, Astragalus membranaceus and Glycyrrhiza glabra on CD69 expression and immune cell activation in humans. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 20(8), 687-695.
  14. Carlsen, M. H., Halvorsen, B. L., Holte, K., Bøhn, S. K., Dragland, S., Sampson, L., … & Barikmo, I. (2010). The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutrition Journal, 9(1), 3.
  15. Carter, G. M., Esmaeili, A., Shah, H., Indyk, D., Johnson, M., Andreae, M., & Sacks, H. S. (2016). Probiotics in human immunodeficiency virus infection: A systematic review and evidence synthesis of benefits and risks. Open Forum Infectious Diseases, 3(4).
  16. Cech, N. B., Junio, H. A., Ackermann, L. W., Kavanaugh, J. S., & Horswill, A. R. (2012). Quorum quenching and antimicrobial activity of goldenseal (Hydrastis canadensis) against methicillin-resistant Staphylococcus aureus (MRSA). Planta Medica, 78(14), 1556-1561.
  17. Cecil, C. E., Davis, J. M., Cech, N. B., & Laster, S. M. (2011). Inhibition of H1N1 influenza A virus growth and induction of inflammatory mediators by the isoquinoline alkaloid berberine and extracts of goldenseal (Hydrastis canadensis). International Immunopharmacology, 11(11), 1706-1714.
  18. Chang, S. W., & Lee, H. C. (2019). Vitamin D and health-the missing vitamin in humans. Pediatrics & Neonatology, 60(3), 237-244.
  19. Charan, J., Goyal, J. P., Saxena, D., & Yadav, P. (2012). Vitamin D for prevention of respiratory tract infections: A systematic review and meta-analysis. Journal of Pharmacology & Pharmacotherapeutics, 3(4), 300.
  20. Clement-Kruzel, S., Hwang, S. A., Kruzel, M. C., Dasgupta, A., & Actor, J. K. (2008). Immune modulation of macrophage pro-inflammatory response by goldenseal and Astragalus extracts. Journal of Medicinal Food, 11(3), 493-498.
  21. Cooper, E. L., & Ma, M. J. (2017). Understanding nutrition and immunity in disease management. Journal of Traditional and Complementary Medicine, 7(4), 386-391.
  22. Cunningham-Rundles, S., Ahrné, S., Johann-Liang, R., Abuav, R., Dunn-Navarra, A. M., Grassey, C., … & Cervia, J. S. (2011). Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection. Nutrients, 3(12), 1042-1070.
  23. Cwikla, C., Schmidt, K., Matthias, A., Bone, K. M., Lehmann, R., & Tiralongo, E. (2010). Investigations into the antibacterial activities of phytotherapeutics against Helicobacter pylori and Campylobacter jejuni. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 24(5), 649-656.
  24. Dai, Q., Di Zhang, H. Y., Xie, W., Xin, R., Wang, L., Xu, X., … & Hu, X. (2017). Berberine restricts coxsackievirus B type 3 replication via inhibition of c-Jun N-terminal kinase (JNK) and p38 MAPK activation in vitro. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 23, 1448-1455.
  25. Dai, X., Stanilka, J. M., Rowe, C. A., Esteves, E. A., Nieves Jr, C., Spaiser, S. J., … & Percival, S. S. (2015). Consuming Lentinula edodes (Shiitake) mushrooms daily improves human immunity: A randomized dietary intervention in healthy young adults. Journal of the American College of Nutrition, 34(6), 478-487.
  26. Davidson, L. E., Fiorino, A. M., Snydman, D. R., & Hibberd, P. L. (2011). Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: A randomized double-blind placebo-controlled trial. European Journal of Clinical Nutrition, 65(4), 501-507.
  27. de Araujo, G. V., de Oliveira Junior, M. H., Peixoto, D. M., & Sarinho, E. S. C. (2015). Probiotics for the treatment of upper and lower respiratory-tract infections in children: Systematic review based on randomized clinical trials. Jornal de Pediatria, 91(5), 413-427.
  28. Durmuş, S., & Ülgen, K. Ö. (2017). Comparative interactomics for virus–human protein–protein interactions: DNA viruses versus RNA viruses. FEBS Open Bio, 7(1), 96-107.
  29. Donatini, B. (2014). Control of oral human papillomavirus (HPV) by medicinal mushrooms, Trametes versicolor and Ganoderma lucidum: A preliminary clinical trial. International Journal of Medicinal Mushrooms, 16(5), 497-498.
  30. dos Santos, A. E., Kuster, R. M., Yamamoto, K. A., Salles, T. S., Campos, R., de Meneses, M. D., … & Ferreira, D. (2014). Quercetin and quercetin 3-O-glycosides from Bauhinia longifolia (Bong.) Steud. show anti-Mayaro virus activity. Parasites & Vectors, 7(1), 130.
  31. Eckard, A. R., O’Riordan, M. A., Rosebush, J. C., Lee, S. T., Habib, J. G., Ruff, J. H., … & Chahroudi, A. (2018). Vitamin D supplementation decreases immune activation and exhaustion in HIV-1-infected youth. Antiviral Therapy, 23(4), 315-324.
  32. Eguchi, N., Fujino, K., Thanasut, K., Taharaguchi, M., Motoi, M., Motoi, A., … & Taharaguchi, S. (2017). In vitro anti-influenza virus activity of Agaricus brasiliensis KA21. Biocontrol Science, 22(3), 171-174.
  33. Eskeland, B., Baerheim, A., Ulvik, R., & Hunskaar, S. (2002). Influence of mild infections on iron status parameters in women of reproductive age. Scandinavian Journal of Primary Health Care, 20(1), 50-56.
  34. Gaullier, J. M., Sleboda, J., Ofjord, E. S., Ulvestad, E., Nurminiemi, M., Moe, C., … & Gudmundsen, O. (2011). Supplementation with a soluble beta-glucan exported from Shiitake medicinal mushroom, Lentinus edodes (Berk.) singer mycelium: A crossover, placebo-controlled study in healthy elderly. International journal of medicinal mushrooms, 13(4), 319-326.
  35. Gentile, F., Arcaro, A., Pizzimenti, S., Daga, M., Cetrangolo, G. P., Dianzani, C., … & Barrera, G. (2017). DNA damage by lipid peroxidation products: Implications in cancer, inflammation and autoimmunity. AIMS Genetics, 4(2), 103.
  36. Ghosh, S., Smriga, M., Vuvor, F., Suri, D., Mohammed, H., Armah, S. M., & Scrimshaw, N. S. (2010). Effect of lysine supplementation on health and morbidity in subjects belonging to poor peri-urban households in Accra, Ghana. The American Journal of Clinical Nutrition, 92(4), 928-939.
  37. Gilling, D. H., Kitajima, M., Torrey, J. R., & Bright, K. R. (2014). Antiviral efficacy and mechanisms of action of oregano essential oil and its primary component carvacrol against murine norovirus. Journal of Applied Microbiology, 116(5), 1149-1163.
  38. Goel, V., Lovlin, R., Chang, C., Slama, J. V., Barton, R., Gahler, R., … & Basu, T. K. (2005). A proprietary extract from the Echinacea plant (Echinacea purpurea) enhances systemic immune response during a common cold. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 19(8), 689-694.
  39. Goncalves-Mendes, N., Talvas, J., Dualé, C., Guttmann, A., Corbin, V., Marceau, G., … & Vasson, M. P. (2019). Impact of vitamin D supplementation on influenza vaccine response and immune functions in deficient elderly persons: A randomized placebo-controlled trial. Frontiers in Immunology, 10, 65.
  40. Gordon, M., Guralnik, M., Kaneko, Y., Mimura, T., Goodgame, J., DeMarzo, C., … & Lang, W. (1995). A phase II controlled study of a combination of the immune modulator, lentinan, with didanosine (ddI) in HIV patients with CD4 cells of 200-500/mm3. Journal of Medicine, 26(5-6), 193-207.
  41. Griffith, R. S., Walsh, D. E., Myrmel, K. H., Thompson, R. W., & Behforooz, A. (1987). Success of L-lysine therapy in frequently recurrent herpes simplex infection. Dermatology, 175(4), 183-190.
  42. Gu, W., Yang, Y. Z., & He, M. X. (1996). A study on combination therapy of Western and traditional Chinese medicine of acute viral myocarditis. Chinese Journal of Integrated Traditional and Western Medicine, 16(12), 713-716.
  43. Hao, Q., Dong, B. R., & Wu, T. (2015). Probiotics for preventing acute upper respiratory tract infections. Cochrane Database of Systematic Reviews, (2), CD006895.
  44. Hawkins, J., Baker, C., Cherry, L., & Dunne, E. (2019). Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta-analysis of randomized, controlled clinical trials. Complementary Therapies in Medicine, 42, 361-365.
  45. Heinz, S. A., Henson, D. A., Austin, M. D., Jin, F., & Nieman, D. C. (2010). Quercetin supplementation and upper respiratory tract infection: A randomized community clinical trial. Pharmacological Research, 62(3), 237-242.
  46. Hemilä, H. (2017). Zinc lozenges and the common cold: A meta-analysis comparing zinc acetate and zinc gluconate, and the role of zinc dosage. JRSM Open, 8(5), 2054270417694291.
  47. Hemilä, H., & Chalker, E. (2015). The effectiveness of high dose zinc acetate lozenges on various common cold symptoms: A meta-analysis. BMC Family Practice, 16(1), 24.
  48. Hemilä, H., & Chalker, E. (2013). Vitamin C for preventing and treating the common cold. Cochrane Database of Systematic Reviews, (1).
  49. Hemilä, H., Fitzgerald, J. T., Petrus, E. J., & Prasad, A. (2017). Zinc acetate lozenges may improve the recovery rate of common cold patients: An individual patient data meta-analysis. Open Forum Infectious Diseases, 4(2).
  50. Hemilä, H., Petrus, E. J., Fitzgerald, J. T., & Prasad, A. (2016). Zinc acetate lozenges for treating the common cold: An individual patient data meta‐analysis. British Journal of Clinical Pharmacology, 82(5), 1393-1398.
  51. Herrington, C. S., Coates, P. J., & Duprex, W. P. (2015). Viruses and disease: Emerging concepts for prevention, diagnosis and treatment. The Journal of Pathology, 235(2), 149-152.
  52. Hsu, C. H., Hwang, K. C., Chiang, Y. H., & Chou, P. (2008). The mushroom Agaricus blazei Murill extract normalizes liver function in patients with chronic hepatitis B. The Journal of Alternative and Complementary Medicine, 14(3), 299-301.
  53. Hu, Y. C., Wang, W. W., Jiang, W. Y., Li, C. Q., Guo, J. C., & Xun, Y. H. (2019). Low vitamin D levels are associated with high viral loads in patients with chronic hepatitis B: A systematic review and meta-analysis. BMC Gastroenterology, 19(1), 84.
  54. Huang, Z. Q., Qin, N. P., & Ye, W. (1995). Effect of Astragalus membranaceus on T-lymphocyte subsets in patients with viral myocarditis. Chinese Journal of Integrated Traditional and Western Medicine, 15(6), 328-330.
  55. Hung, T. C., Jassey, A., Liu, C. H., Lin, C. J., Lin, C. C., Wong, S. H., … & Lin, L. T. (2019). Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein. Phytomedicine, 53, 62-69.
  56. Jawad, M., Schoop, R., Suter, A., Klein, P., & Eccles, R. (2012). Safety and efficacy profile of Echinacea purpurea to prevent common cold episodes: A randomized, double-blind, placebo-controlled trial. Evidence-Based Complementary and Alternative Medicine, 2012, 841315.
  57. Johnstone, J., Roth, D. E., Guyatt, G., & Loeb, M. (2012). Zinc for the treatment of the common cold: A systematic review and meta-analysis of randomized controlled trials. CMAJ, 184(10), E551-E561.
  58. Kang, E. J., Kim, S. Y., Hwang, I. H., & Ji, Y. J. (2013). The effect of probiotics on prevention of common cold: A meta-analysis of randomized controlled trial studies. Korean journal of family medicine, 34(1), 2.
  59. Karsch‐Völk, M., Barrett, B., Kiefer, D., Bauer, R., Ardjomand‐Woelkart, K., & Linde, K. (2014). Echinacea for preventing and treating the common cold. Cochrane Database of Systematic Reviews, (2), CD000530.
  60. Kazemi, A., Djafarian, K., Speakman, J. R., Sabour, P., Soltani, S., & Shab-Bidar, S. (2018). Effect of probiotic supplementation on CD4 cell count in HIV-infected patients: A systematic review and meta-analysis. Journal of Dietary Supplements, 15(5), 776-788.
  61. Khachatoorian, R., Arumugaswami, V., Raychaudhuri, S., Yeh, G. K., Maloney, E. M., Wang, J., … & French, S. W. (2012). Divergent antiviral effects of bioflavonoids on the hepatitis C virus life cycle. Virology, 433(2), 346-355.
  62. Kim, H. B., Myung, S. K., Lee, Y. J., Park, B. J., & Korean Meta‐Analysis (KORMA) Study Group. (2018). Efficacy of vitamin D supplementation in combination with conventional antiviral therapy in patients with chronic hepatitis C infection: A meta‐analysis of randomised controlled trials. Journal of Human Nutrition and Dietetics, 31(2), 168-177.
  63. Kim, Y., Narayanan, S., & Chang, K. O. (2010). Inhibition of influenza virus replication by plant-derived isoquercetin. Antiviral Research, 88(2), 227-235.
  64. King, S., Glanville, J., Sanders, M. E., Fitzgerald, A., & Varley, D. (2014). Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: A systematic review and meta-analysis. British Journal of Nutrition, 112(1), 41-54.
  65. Kirchberger, S., Majdic, O., & Stöckl, J. (2007). Modulation of the immune system by human rhinoviruses. International Archives of Allergy and Immunology, 142(1), 1-10.
  66. Kong, F. K. (2009). Pilot clinical study on a proprietary elderberry extract: Efficacy in addressing influenza symptoms. Online Journal of Pharmacology and Pharmacokinetics, 5, 32-43.
  67. Koonin, E. V., Dolja, V. V., & Krupovic, M. (2015). Origins and evolution of viruses of eukaryotes: The ultimate modularity. Virology, 479, 2-25.
  68. Lani, R., Hassandarvish, P., Chiam, C. W., Moghaddam, E., Chu, J. J. H., Rausalu, K., … & Zandi, K. (2015). Antiviral activity of silymarin against chikungunya virus. Scientific Reports, 5, 11421.
  69. Lee, S., Kim, J. I., Heo, J., Lee, I., Park, S., Hwang, M. W., … & Park, M. S. (2013). The anti-influenza virus effect of Phellinus igniarius extract. Journal of microbiology, 51(5), 676-681.
  70. Lee, M., Son, M., Ryu, E., Shin, Y. S., Kim, J. G., Kang, B. W., … & Kang, H. (2015). Quercetin-induced apoptosis prevents EBV infection. Oncotarget, 6(14), 12603.
  71. Lei, W. T., Shih, P. C., Liu, S. J., Lin, C. Y., & Yeh, T. L. (2017). Effect of probiotics and prebiotics on immune response to influenza vaccination in adults: A systematic review and meta-analysis of randomized controlled trials. Nutrients, 9(11), 1175.
  72. Leyer, G. J., Li, S., Mubasher, M. E., Reifer, C., & Ouwehand, A. C. (2009). Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics, 124(2), e172-e179.
  73. Leyva-López, N., Gutiérrez-Grijalva, E. P., Vazquez-Olivo, G., & Heredia, J. B. (2017). Essential oils of oregano: Biological activity beyond their antimicrobial properties. Molecules, 22(6), 989.
  74. Liang, Y., Zhang, Q., Zhang, L., Wang, R., Xu, X., & Hu, X. (2019). Astragalus membranaceus treatment protects raw264. 7 cells from influenza virus by regulating G1 phase and the TLR3-mediated signaling pathway. Evidence-Based Complementary and Alternative Medicine, 2019, 2971604.
  75. Lin, L. T., Hsu, W. C., & Lin, C. C. (2014). Antiviral natural products and herbal medicines. Journal of Traditional and Complementary Medicine, 4(1), 24-35.
  76. Liu, Z. L., Liu, Z. J., Liu, J. P., & Kwong, J. S. (2013). Herbal medicines for viral myocarditis. Cochrane Database of Systematic Reviews, (8), CD003711.
  77. Lodish, H., Berk, A., Zipursky, S. L., Matsudaira, P., Baltimore, D., & Darnell, J. (2000). Viruses: Structure, function, and uses. In Molecular Cell Biology. 4th edition. WH Freeman.
  78. Loeb, M., Dang, A. D., Thiem, V. D., Thanabalan, V., Wang, B., Nguyen, N. B., … & Maguire, J. (2019). Effect of vitamin D supplementation to reduce respiratory infections in children and adolescents in Vietnam: a randomized controlled trial. Influenza and Other Respiratory Viruses, 13(2), 176-183.
  79. Mailoo, V. J., & Rampes, S. (2017). Lysine for herpes simplex prophylaxis: A review of the evidence. Integrative Medicine: A Clinician’s Journal, 16(3), 42.
  80. Mao, S. P., Cheng, K. L., & Zhou, Y. F. (2004). Modulatory effect of Astragalus membranaceus on Th1/Th2 cytokine in patients with herpes simplex keratitis. Chinese Journal of Integrated Traditional and Western Medicine, 24(2), 121-123.
  81. McCulloch, M., Broffman, M., Gao, J., & Colford Jr, J. M. (2002). Chinese herbal medicine and interferon in the treatment of chronic hepatitis B: A meta-analysis of randomized, controlled trials. American Journal of Public Health, 92(10), 1619-1628.
  82. McCune, M. A., Perry, H. O., Muller, S. A., & O’Fallon, W. M. (1984). Treatment of recurrent herpes simplex infections with L-lysine monohydrochloride. Cutis, 34(4), 366-373.
  83. Milajerdi, A., Mousavi, S. M., Sadeghi, A., Salari-Moghaddam, A., Parohan, M., Larijani, B., & Esmaillzadeh, A. (2019). The effect of probiotics on inflammatory biomarkers: A meta-analysis of randomized clinical trials. European Journal of Nutrition, 59(2), 633-649.
  84. Miller, H., Ferris, R., & Phelps, B. R. (2016). The effect of probiotics on CD4 counts among people living with HIV: A systematic review. Beneficial Microbes, 7(3), 345-351.
  85. Milman, N., Scheibel, J., & Jessen, O. (1980). Lysine prophylaxis in recurrent herpes simplex labialis: A double-blind, controlled crossover study. Acta Dermato-venereologica, 60(1), 85-87.
  86. Moyad, M. A., Robinson, L. E., Zawada Jr, E. T., Kittelsrud, J. M., Chen, D. G., Reeves, S. G., & Weaver, S. E. (2008). Effects of a modified yeast supplement on cold/flu symptoms. Urol Nurs, 28(1), 50-55.
  87. Moyad, M. A., Robinson, L. E., Zawada Jr, E. T., Kittelsrud, J., Chen, D. G., Reeves, S. G., & Weaver, S. (2010). Immunogenic yeast-based fermentate for cold/flu-like symptoms in nonvaccinated individuals. The Journal of Alternative and Complementary Medicine, 16(2), 213-218.
  88. National Center for Complementary and Integrative Health. (2016). Goldenseal. Retrieved March 13th, 2020 from
  89. Nieman, D. C., Henson, D. A., Gross, S. J., Jenkins, D. P., Davis, J. M., Murphy, E. A., … & McAnulty, L. S. (2007). Quercetin reduces illness but not immune perturbations after intensive exercise. Medicine & Science in Sports & Exercise, 39(9), 1561-1569.
  90. Noroozi, M., Angerson, W. J., & Lean, M. E. (1998). Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes. The American Journal of Clinical Nutrition, 67(6), 1210-1218.
  91. Olivares, M., Díaz-Ropero, M. P., Sierra, S., Lara-Villoslada, F., Fonollá, J., Navas, M., … & Xaus, J. (2007). Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition, 23(3), 254-260.
  92. Ozen, M., Kocabas Sandal, G., & Dinleyici, E. C. (2015). Probiotics for the prevention of pediatric upper respiratory tract infections: A systematic review. Expert Opinion on Biological Therapy, 15(1), 9-20.
  93. Park, G. B., Hur, D. Y., Kim, Y. S., Lee, H. K., Yang, J. W., & Kim, D. (2015). TLR 3/TRIF signalling pathway regulates IL‐32 and IFN‐β secretion through activation of RIP‐1 and TRAF in the human cornea. Journal of Cellular and Molecular Medicine, 19(5), 1042-1054.
  94. Parvez, M. K., & Parveen, S. (2017). Evolution and emergence of pathogenic viruses: Past, present, and future. Intervirology, 60(1-2), 1-7.
  95. Paunović, M. G., Ognjanović, B. I., Matić, M. M., Štajn, A. Š., & Saičić, Z. S. (2016). Protective effects of quercetin and vitamin C against nicotine-induced toxicity in the blood of Wistar rats. Archives of Industrial Hygiene and Toxicology, 67(4), 304-310.
  96. Pavia, A. T. (2011). Viral infections of the lower respiratory tract: Old viruses, new viruses, and the role of diagnosis. Clinical Infectious Diseases, 52(4), S284-S289.
  97. Piraino, F., & Brandt, C. R. (1999). Isolation and partial characterization of an antiviral, RC-183, from the edible mushroom Rozites caperata. Antiviral Research, 43(2), 67-78.
  98. Pletz, M. W., Terkamp, C., Schumacher, U., Rohde, G., Schütte, H., Welte, T., … & CAPNETZ-Study Group. (2014). Vitamin D deficiency in community-acquired pneumonia: Low levels of 1, 25 (OH) 2 D are associated with disease severity. Respiratory Research, 15(1), 53.
  99. Prasad, A. S., Beck, F. W., Bao, B., Fitzgerald, J. T., Snell, D. C., Steinberg, J. D., & Cardozo, L. J. (2007). Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. The American Journal of Clinical Nutrition, 85(3), 837-844.
  100. Prasad, A. S., Beck, F. W. J., Bao, B., Snell, D., & Fitzgerald, J. T. (2008). Duration and severity of symptoms and levels of plasma interleukin-1 receptor antagonist, soluble tumor necrosis factor receptor, and adhesion molecules in patients with common cold treated with zinc acetate. The Journal of Infectious Diseases, 197(6), 795-802.
  101. Qiu, X., Kroeker, A., He, S., Kozak, R., Audet, J., Mbikay, M., & Chrétien, M. (2016). Prophylactic efficacy of quercetin 3-β-Od-glucoside against Ebola virus infection. Antimicrobial Agents and Chemotherapy, 60(9), 5182-5188.
  102. Ran, L., Zhao, W., Wang, J., Wang, H., Zhao, Y., Tseng, Y., & Bu, H. (2018). Extra dose of vitamin C based on a daily supplementation shortens the common cold: A meta-analysis of 9 randomized controlled trials. BioMed Research International, 2018.
  103. Razonable, R. R. (2011). Antiviral drugs for viruses other than human immunodeficiency virus. Mayo Clinic Proceedings, 86(10), 1009-1026.
  104. Rehman, J., Dillow, J. M., Carter, S. M., Chou, J., Le, B., & Maisel, A. S. (1999). Increased production of antigen-specific immunoglobulins G and M following in vivo treatment with the medicinal plants Echinacea angustifolia and Hydrastis canadensis. Immunology Letters, 68(2-3), 391-395.
  105. Roman, B. E., Beli, E., Duriancik, D. M., & Gardner, E. M. (2013). Short-term supplementation with active hexose correlated compound improves the antibody response to influenza B vaccine. Nutrition Research, 33(1), 12-17.
  106. Roshan, H., Ghaedi, E., Rahmani, J., Barati, M., Najafi, M., Karimzedeh, M., & Nikpayam, O. (2019). Effects of probiotics and synbiotic supplementation on antioxidant status: A meta-analysis of randomized clinical trials. Clinical Nutrition ESPEN, 30, 81-88.
  107. Sewald, X., Motamedi, N., & Mothes, W. (2016). Viruses exploit the tissue physiology of the host to spread in vivo. Current Opinion in Cell Biology, 41, 81-90.
  108. Shah, S. A., Sander, S., White, C. M., Rinaldi, M., & Coleman, C. I. (2007). Evaluation of echinacea for the prevention and treatment of the common cold: A meta-analysis. The Lancet: Infectious Diseases, 7(7), 473-480.
  109. Shimizu, Y., Ito, Y., Yui, K., Egawa, K., & Orimo, H. (2018). Intake of 25-hydroxyvitamin D3 reduces duration and severity of upper respiratory tract infection: A randomized, double-blind, placebo-controlled, parallel group comparison study. The Journal of Nutrition, Health & Aging, 22(4), 491-500.
  110. Shin, H. B., Choi, M. S., Yi, C. M., Lee, J., Kim, N. J., & Inn, K. S. (2015). Inhibition of respiratory syncytial virus replication and virus-induced p38 kinase activity by berberine. International Immunopharmacology, 27(1), 65-68.
  111. Singh, B. B., Udani, J., Vinjamury, S. P., Der-Martirosian, C., Gandhi, S., Khorsan, R., … & Singh, V. (2005). Safety and effectiveness of an L-lysine, zinc, and herbal-based product on the treatment of facial and circumoral herpes. Altern Med Rev, 10(2), 123-7.
  112. Singh, M., & Das, R. R. (2015). Zinc for the common cold. Cochrane Database of Systematic Reviews, 2015(4), CD001364.
  113. Singh, M., Rao, D. M., Pande, S., Battu, S., Dutt, K. R., & Ramesh, M. (2011). Medicinal uses of L-lysine: Past and future. International Journal of Research in Pharmaceutical Sciences, 2(4), 637-642.
  114. Tang, L. L., Sheng, J. F., Xu, C. H., & Liu, K. Z. (2009). Clinical and experimental effectiveness of Astragali compound in the treatment of chronic viral hepatitis B. Journal of International Medical Research, 37(3), 662-667.
  115. Thaker, S. K., Ch’ng, J., & Christofk, H. R. (2019). Viral hijacking of cellular metabolism. BMC Biology, 17(1), 59.
  116. Thein, D. J., & Hurt, W. C. (1984). Lysine as a prophylactic agent in the treatment of recurrent herpes simplex labialis. Oral Surgery, Oral Medicine, Oral Pathology, 58(6), 659-666.
  117. Tiralongo, E., Wee, S. S., & Lea, R. A. (2016). Elderberry supplementation reduces cold duration and symptoms in air-travellers: A randomized, double-blind placebo-controlled clinical trial. Nutrients, 8(4), 182.
  118. Urashima, M., Segawa, T., Okazaki, M., Kurihara, M., Wada, Y., & Ida, H. (2010). Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. The American Journal of Clinical Nutrition, 91(5), 1255-1260.
  119. Villar, L. M., Del Campo, J. A., Ranchal, I., Lampe, E., & Romero-Gomez, M. (2013). Association between vitamin D and hepatitis C virus infection: A meta-analysis. World Journal of Gastroenterology: WJG, 19(35), 5917.
  120. Wang, Y., Li, X., Ge, T., Xiao, Y., Liao, Y., Cui, Y., … & Zhang, T. (2016). Probiotics for prevention and treatment of respiratory tract infections in children: A systematic review and meta-analysis of randomized controlled trials. Medicine, 95(31), e4509.
  121. Wang, Y. X., Yang, L., Wang, H. Q., Zhao, X. Q., Liu, T., Li, Y. H., … & Song, D. Q. (2018). Synthesis and evolution of berberine derivatives as a new class of antiviral agents against enterovirus 71 through the MEK/ERK pathway and autophagy. Molecules, 23(8), 2084.
  122. Wilson, N. L., Moneyham, L. D., & Alexandrov, A. W. (2013). A systematic review of probiotics as a potential intervention to restore gut health in HIV infection. Journal of the Association of Nurses in AIDS Care, 24(2), 98-111.
  123. Yan, Y. Q., Fu, Y. J., Wu, S., Qin, H. Q., Zhen, X., Song, B. M., … & Jiang, Z. Y. (2018). Anti‐influenza activity of berberine improves prognosis by reducing viral replication in mice. Phytotherapy Research, 32(12), 2560-2567.
  124. Yang, Y. Z., Jin, P. Y., Guo, Q., Wang, Q. D., Li, Z. S., Ye, Y. C., … & Pu, S. Y. (1990). Effect of Astragulas membranaceus on natural killer cell activity and induction of alpha-and gamma-interferon in patients with Coxsackie B viral myocarditis. Chinese Medical Journal, 103(4), 304-307.
  125. Yeh, T. L., Shih, P. C., Liu, S. J., Lin, C. H., Liu, J. M., Lei, W. T., & Lin, C. Y. (2018). The influence of prebiotic or probiotic supplementation on antibody titers after influenza vaccination: A systematic review and meta-analysis of randomized controlled trials. Drug Design, Development and Therapy, 12, 217.
  126. Zakay-Rones, Z., Thom, E., Wollan, T., & Wadstein, J. (2004). Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections. Journal of International Medical Research, 32(2), 132-140.
  127. Zakay-Rones, Z., Varsano, N., Zlotnik, M., Manor, O., Regev, L., Schlesinger, M., & Mumcuoglu, M. (1995). Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama. The Journal of Alternative and Complementary Medicine, 1(4), 361-369.
  128. Zamani, B., Sheikhi, A., Namazi, N., Larijani, B., & Azadbakht, L. (2019). The Effects of Supplementation with probiotic on biomarkers of oxidative stress in adult subjects: A systematic review and meta-analysis of randomized trials. Probiotics and Antimicrobial Proteins, 1-10.
  129. Zhang, X. L., Guo, Y. S., Wang, C. H., Li, G. Q., Xu, J. J., Chung, H. Y., … & Wang, G. C. (2014). Phenolic compounds from Origanum vulgare and their antioxidant and antiviral activities. Food Chemistry, 152, 300-306.
  130. Zhou, J., Du, J., Huang, L., Wang, Y., Shi, Y., & Lin, H. (2018). Preventive effects of vitamin D on seasonal influenza A in infants: A multicenter, randomized, open, controlled clinical trial. The Pediatric Infectious Disease Journal, 37(8), 749-754.
  131. Zhou, R., Liu, Z. K., Zhang, Y. N., Wong, J. H., Ng, T. B., & Liu, F. (2019). Research progress of bioactive proteins from the edible and medicinal mushrooms. Current Protein and Peptide Science, 20(3), 196-219.
  132. Zhuang, W., Li, T., Wang, C., Shi, X., Li, Y., Zhang, S., … & Qiao, Y. (2018). Berberine exerts antioxidant effects via protection of spiral ganglion cells against cytomegalovirus-induced apoptosis. Free Radical Biology and Medicine, 121, 127-135.
  133. Zhuang, Z., Wang, Z. H., Deng, L. H., Zheng, Q., Zheng, G. Q., & Wang, Y. (2019). Astragaloside IV exerts cardioprotection in animal models of viral myocarditis: A preclinical systematic review and meta-analysis. Frontiers in Pharmacology, 10, 1388.
  134. Zwickey, H., Brush, J., Iacullo, C. M., Connelly, E., Gregory, W. L., Soumyanath, A., & Buresh, R. (2007). The effect of Echinacea purpurea, Astragalus membranaceus and Glycyrrhiza glabra on CD25 expression in humans: A pilot study. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 21(11), 1109-1112.

Fullscript content philosophy

At Fullscript, we are committed to curating accurate, and reliable educational content for practitioners and patients alike. Our educational offerings cover a broad range of topics related to integrative medicine, such as supplement ingredients, diet, lifestyle, and health conditions.

Medically reviewed by expert practitioners and our internal Integrative Medical Advisory team, all Fullscript content adheres to the following guidelines:

  1. In order to provide unbiased and transparent education, information is based on a research review and obtained from trustworthy sources, such as peer-reviewed articles and government websites. All medical statements are linked to the original reference and all sources of information are disclosed within the article.
  2. Information about supplements is always based on ingredients. No specific products are mentioned or promoted within educational content.
  3. A strict policy against plagiarism is maintained; all our content is unique, curated by our team of writers and editors at Fullscript. Attribution to individual writers and editors is clearly stated in each article.
  4. Resources for patients are intended to be educational and do not replace the relationship between health practitioners and patients. In all content, we clearly recommend that readers refer back to their healthcare practitioners for all health-related questions.
  5. All content is updated on a regular basis to account for new research and industry trends, and the last update date is listed at the top of every article.
  6. Potential conflicts of interest are clearly disclosed.
Send this to a friend